BÖLÜM 2: Kanser Biyolojisi
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
Kokai Y, Myers JN, Wada T et al. Synergistic interaction of p185cneu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 1989; 58(2): 287-292.
Foster CS, Falconer A, Dodson AR et al. Transcription factor E2F3
overexpressed in prostate cancer independently predicts clinical
outcome. Oncogene 2004; 23(35): 5871-589.
Brown T. Genome replication. In: Genomes. New York, NY: Garland Science; 2007. p.467-499.
Pollard T, Earnshaw WC. Introduction to the cell cycle. In: Cell Biology. 2. ed., Philadelphia, PA: Saunders Elsevier. 2008. p.731-746
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;
100(1): 57-70.
Evan GI, Wyllic AH, Gilbert CS et al. Induction of apoptosis in fibroblasts by c-myc protein. 1992; Cell 69(1): 119-128.
Milner AE, Grand RJ, Waters CM, Gregory CD. Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 1993; 8(12):
3385-3391.
Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer
cell lines. Nature 1983; 306(5939): 194-196.
Kozbor D, Croce CM. Amplification of the c-myc oncogene in one
of five human breast carcinoma cell lines. Cancer Res 1984; 44(2):
438-441.
Dalla-Favera R, Bregni M, Erikson J et al. Human c-myc onc gene is
located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79(24); 78247827.
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine
plasmacytoma cells. Proc Natl Acad Sci USA. 1982; 79(24): 78377841.
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisman
RN, Golub TR. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle,
signaling, and adhesion. Proc Natl Acad Sci USA 2000; 97(7): 32603265.
Menssen A, Hermeking H. Characterization of the c-MYC-regulated
transcriptome by SAGE: identification and analysis of c-MYC target
genes. Proc Natl Acad Sci USA 2002: 99(9): 6274-6279.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
17
Kohl NE, Gee CE, Alt FW. Activated expression of the N-myc
gene in human neuroblastomas and related tumors. Science 1984;
226(4680): 1335-1337.
Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 1984;
309(5967): 458-460.
Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF et al. L-myc, a
new myc-related gene amplified and expressed in human small cell
lung cancer. Nature 1985: 318(6041): 69-73.
Zhang Y, Rowley JD. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 2006; 5(9-10): 12821297
Weinberg RA. Oncogenes and tumor suppressor genes. CA: Cancer J Clin 1994; 44(3): 160-170.
Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997; 386(6627): 761- 763.
Esteller M. Epigenetics and Cancer. N Engl J Med 2008; 358(11):
1148-1159.
Junttila MR, Evan GI. p53-a Jack of all trades but master of none.
Nat Rev Cancer 2009; 9(11): 821-829: 2009.
Hesketh R. The oncogene and tumor suppressor gene facts book.
2nd ed. London: Academic Press. 1997. p.405-489.
Burkhart DL, Sage J. Cellular mechanisms of tumour suppression
by the retinoblastoma gene. Nat Rev Cancer. 2008; 8(9): 671-672.
Orr-Weaver TL, Weinberg RA. A checkpoint on the road to cancer.
Nature. 1998; 392(6673): 223-224.
Hoeijmakers JH. Genome maintenance mechanisms for preventing
cancer.Nature 2001; 411 (6835): 366-374.
Pallis AG, Karamouzis MV. DNA repair pathways and their implication in cancer treatment.Cancer Met. Rev. 2010; 29(4): 677684.
Nowell PC, Hungerford DA. A minute chromosome in human
chronic myelocytic leukemia (CML). Science